Gardasil royalties are about 20% of CSL's profit, and these are mooted to fall about 20%, and hence the negative impact is some 4%. The market has over reacted to the news that the USA licensee of Gardasil had lowered sales forecasts.
The foregoing arithmetic is a rough approximation, and 4% might be too high, but the thrust of what I write here is probably correct.
Pioupiou
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$250.66 |
Change
9.060(3.75%) |
Mkt cap ! $121.3B | |||
| Open | High | Low | Value | Volume |
| $241.26 | $250.74 | $241.26 | $215.9M | 868.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11 | $250.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $250.70 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |